CRISPR Therapeutics AG

24 sie 2026, 23:01 UTC

Shares of CRISPR Therapeutics AG declined in after-market trading, despite briefly recovering earlier in the session. The stock remains above its 20-day moving average.

21 sie 2026, 23:36 UTC

CRISPR Therapeutics AG shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the one-month range's upper end.

20 sie 2026, 19:51 UTC

Shares lower today amid broader market pressures; SPDR S&P Biotech declines.

19 sie 2026, 23:01 UTC

CRISPR Therapeutics AG shares are lower in after-market trading, continuing a decline since Wednesday's close amid notable volatility.

18 sie 2026, 22:16 UTC

CRISPR Therapeutics AG shares are lower in after-market trading, reflecting unusual downward momentum amid broader market declines in major U.S. tech stocks.

17 sie 2026, 23:06 UTC

CRISPR Therapeutics AG shares are lower in after-market trading, reflecting broader market sentiment affecting small-cap stocks amid a slight decline in the Russell 2000 Index.

14 sie 2026, 19:16 UTC

CRISPR Therapeutics AG shares are lower today amid broader investor caution following a decline in U.S. retail sales for July.

13 sie 2026, 23:46 UTC

CRISPR Therapeutics AG shares are higher in after-market trading, reflecting a positive trend in the biotechnology sector amid favorable economic conditions.

11 sie 2026, 19:21 UTC

CRISPR Therapeutics AG shares are trading higher amid rising oil prices and inflation concerns ahead of upcoming U.S. inflation data. No specific news was identified.

10 sie 2026, 23:06 UTC

No specific news was identified for CRISPR Therapeutics AG, which traded roughly flat during after-market hours, remaining near the upper end of its one-month range.

7 sie 2026, 20:06 UTC

CRISPR Therapeutics AG is gaining amid positive social media sentiment and bullish chart patterns, aligning with the upward trend in the ARK Genomic Revolution ETF.

6 sie 2026, 22:06 UTC

CRISPR Therapeutics AG shares are higher in after-market hours, aligning with positive trends in the biotechnology sector and maintaining a position above its 20-day moving average.

5 sie 2026, 23:16 UTC

CRISPR Therapeutics AG shares traded lower in after-market hours, settling above the 20-day moving average and within the middle of its one-month range.

4 sie 2026, 23:56 UTC

CRISPR Therapeutics AG shares are lower in after-market trading, following a volatile session with no specific news identified to explain the movement.

3 sie 2026, 23:02 UTC

CRISPR Therapeutics reported second-quarter revenue of $10.18 million, exceeding expectations. Shares are trading higher in after-market hours following the earnings report.

31 lip 2026, 23:06 UTC

Shares of CRISPR Therapeutics AG are trading higher in after-market hours. The stock remains near the lower end of its one-month trading range.

30 lip 2026, 23:02 UTC

CRISPR Therapeutics shares are lower in after-market hours amid broader market weakness, despite analysts projecting revenue growth and a price target of $83.53.

29 lip 2026, 22:01 UTC

CRISPR Therapeutics AG shares are lower in after-market trading amid broader market declines driven by geopolitical tensions and caution ahead of the Fed's interest rate decision.

28 lip 2026, 23:01 UTC

CRISPR Therapeutics AG shares are lower in after-market trading, reflecting broader market trends and a decline in the Russell 2000 Index.

27 lip 2026, 19:07 UTC

CRISPR Therapeutics AG shares are higher today, gaining since Friday's close. The stock peaked earlier in the session before pulling back.

23 lip 2026, 10:36 UTC

CRISPR Therapeutics AG shares are roughly flat in pre-market hours, with no specific company news identified. The stock remains near the lower end of its trading range.

22 lip 2026, 23:06 UTC

CRISPR Therapeutics AG shares are trading higher in after-market hours, though they remain below their 20-day moving average and near the lower end of their one-month range.

21 lip 2026, 19:26 UTC

CRISPR Therapeutics AG shares are higher today, buoyed by a strong gene-editing pipeline and positive analyst sentiment regarding its lead asset, CASGEVY.

20 lip 2026, 23:22 UTC

CRISPR Therapeutics AG is trading higher in after-market hours, despite broader market declines linked to rising treasury yields. No specific news was identified.